Clinical Trial: Ultrasound and Endometrial Hyperplasia
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Development of a Screening Test for Endometrial Hyperplasia in an At Risk Cohort
Brief Summary: The investigators hypothesize that endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with metabolic syndrome: diabetes and/or insulin resistance, hypertension, and obesity.
Detailed Summary: The objective is to identify the utility of ultrasound as a screening test for endometrial hyperplasia and cancer in an "at risk" cohort. Endometrial carcinoma is an understudied cancer. This study will provide benefit regardless of its outcome, because it will be the first prospectively designed screening trial in an asymptomatic population.
Sponsor: Milton S. Hershey Medical Center
Current Primary Outcome: Endometrial Hyperplasia [ Time Frame: End of study ]
Original Primary Outcome: Our objective is to identify the utility of ultrasound as a screening test for endometrial hyperplasia and cancer in an "at risk" cohort.
Current Secondary Outcome: Endometrial Cancer [ Time Frame: End of study ]
Original Secondary Outcome: We propose that this metabolic syndrome is also a risk factor for endometrial hyperplasia and cancer.
Information By: Milton S. Hershey Medical Center
Dates:
Date Received: July 20, 2005
Date Started: April 2005
Date Completion:
Last Updated: January 16, 2015
Last Verified: January 2015